Search for a trial

1 results

HLA-A02 TESTING USING ONE LAMBDAS SECORE CDX HLA SEQUENCING SYSTEM IN DAIICHI SANKYO*S FIRST-IN-HUMAN STUDY OF DS-2243a IN PARTICIPANTS WITH ADVANCED SOLID TUMORS

Approved WMOPending

The primary objective of this Clinical Performance Study is to utilize the Device for performance evaluation to detect HLA-A Locus alleles as part of the eligibility criteria for patients to receive an experimental medicinal product under the DS2243…

HLA-A*02 TESTING USING ONE LAMBDA*S SECORE CDX HLA SEQUENCING SYSTEM IN DAIICHI SANKYO*S FIRST-IN-HUMAN STUDY OF DS-2243a IN PARTICIPANTS WITH ADVANCED SOLID TUMORS

HLA-A02 TESTING USING ONE LAMBDAS SECORE CDX HLA SEQUENCING SYSTEM IN DAIICHI SANKYO*S FIRST-IN-HUMAN STUDY OF DS-2243a IN PARTICIPANTS WITH ADVANCED SOLID TUMORS